The goal of this clinical research study is to study the safety of REVLIMID® (lenalidomide) when given with YERVOY® (ipilimumab) after a stem cell transplant. Researchers also want to find out if lenalidomide given with ipilimumab may help to control leukemia, lymphoma, and multiple myeloma.